Healthcare Global Enterprises share news, announcements and annual reports
NSE: HCGBSE: 539787Healthcare ServicesSmall Cap
Healthcare Global Enterprises Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2016 · Issue price ₹218
Last close ₹586.80up ₹1.25 (0.21%)BSE ₹586.30
Share price at the NSE close on 2 Nov 2026. Previous close ₹585.55.
2 Nov: open ₹584.00, high ₹594.95, low ₹579.00
52-week range of traded prices to 2 Nov 2026
₹513.30Low, 30 Mar 2026₹775.00High, 31 Aug 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹8,761 Cr593rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 384.59
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 130.06
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.58
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 6.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.65
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 93,12752.5% delivered
Healthcare Global Enterprises disputes and clarifications
14 filed, newest first.
Jun 2026
Apr 2025
16 Apr · Legal
The exchange asked on 15 Apr 2025
Mar 2025
May 2020
19 May · Legal
The exchange asked on 19 May 2020
May 2018
23 May · Legal
Exchange has sought clarification from Healthcare Global Enterprises Limited with respect to announcement dated 22-May-2018, regarding " Healthcare Global Enterprises Limited has informed the Exchange regarding Outcome of Board Meeting held on May 22, 2018.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); The response of the Company is awaited.
Sep 2017
Aug 2017
Nov 2016
10 Nov · Legal
Exchange has sought clarification from Healthcare Global Enterprises Limited with respect to announcement dated 10-Nov-2016, regarding "Healthcare Global Enterprises Limited has informed the Exchange regarding Outcome of Board Meeting held on November 10, 2016.".On basis of above the Company is required to clarify following:1. Brief profile (in case of appointment);2. Disclosure of relationships between directors (in case of appointment of a director).3. Brief profile (in case of appointment);4. Disclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.7 Nov · Legal
Exchange has sought clarification from Healthcare Global Enterprises Limited with respect to an announcement submitted to the Exchange dated November 04, 2016, that the Company has entered in to a Shareholders' Agreement on November 03, 2016.On basis of above Company are required to clarify following -1. Purpose of entering into the agreement;2. Shareholding, if any, in the entity with whom the agreement is executed;3. Significant terms of the agreement (in brief) special rights like right to appoint directors, first right to share subscription in case of issuance of shares, right to restrict any change in capital structure etc.;4. Whether, the said parties are related to promoter/promoter group/ group companies in any manner. If yes, nature of relationship;5. Whether the transaction would fall within related party transactions? If yes, whether the same is done at arms length;6. In case of issuance of shares to the parties, details of issue price, class of shares issued;7. Any other disclosures related to such agreements, viz., details of nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements, etc;The response of the Company is awaited.
Aug 2016
16 Aug · Legal
Exchange has sought clarification from Healthcare Global Enterprises Limited with respect to announcement dated 12-Aug-2016, regarding "Healthcare Global Enterprises Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on August 12, 2016.The board of Directors has appointed Mr. Yogesh Patel as the Chief Financial officer of the Company".On basis of above the Company is required to clarify following:1. Reason for change viz. appointment, resignation, removal, death or otherwise;2. Date of appointment/cessation (as applicable) & term of appointment;3. Brief profile (in case of appointment);4. Dsclosure of relationships between directors (in case of appointment of a director).The response of the Company is awaited.